NCT05162222View on ClinicalTrials.gov

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

July 8, 2022

Study Completion Date

July 8, 2022

Conditions
Healthy Participants
Interventions
DRUG

Danicamtiv

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Diltiazem

Specified dose on specified days

Trial Locations (1)

75247-4968

Covance Clinical Research Unit - Dallas, Dallas

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05162222 - A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants | Biotech Hunter | Biotech Hunter